ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Spidey999
|
5.4K |
2.7M |
8 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Downrampers off-topic erasure
|
|
Spidey999
|
21 |
5.9K |
1 |
26/03/23 |
26/03/23 |
ASX - By Stock
|
21
|
5.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
Spidey999
|
275 |
111K |
4 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
275
|
111K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
Spidey999
|
275 |
111K |
38 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
275
|
111K
|
38
|
|
ASX - By Stock
|
MSB |
Re:
William Blair initiated coverage of MESO
|
|
Spidey999
|
59 |
16K |
7 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
59
|
16K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Spidey999
|
905 |
286K |
3 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
905
|
286K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Spidey999
|
1.0K |
391K |
3 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
Spidey999
|
111 |
41K |
4 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
111
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
More than All-time HIGH of $9.32 (AUD) is POSSIBLE
|
|
Spidey999
|
104 |
41K |
0 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
104
|
41K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Pick the next Low Competition
|
|
Spidey999
|
44 |
13K |
1 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
44
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Breakout
|
|
Spidey999
|
144 |
48K |
2 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
144
|
48K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
DREAM HF Trial Video
|
|
Spidey999
|
99 |
34K |
1 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
99
|
34K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
DREAM HF Trial Video
|
|
Spidey999
|
99 |
34K |
4 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
99
|
34K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
Spidey999
|
914 |
291K |
5 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
914
|
291K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
Spidey999
|
914 |
291K |
1 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
914
|
291K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Spidey999
|
763 |
324K |
1 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
763
|
324K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Spidey999
|
116 |
36K |
0 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
116
|
36K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Spidey999
|
576 |
205K |
21 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
205K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Spidey999
|
778 |
282K |
4 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
778
|
282K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Spidey999
|
4.7K |
1.1M |
4 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Spidey999
|
4.7K |
1.1M |
2 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Spidey999
|
778 |
282K |
1 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
778
|
282K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
Spidey999
|
144 |
56K |
1 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
144
|
56K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Spidey999
|
505 |
160K |
4 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
505
|
160K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
Spidey999
|
124 |
38K |
0 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
124
|
38K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spidey999
|
10K |
3.0M |
8 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
Spidey999
|
124 |
38K |
0 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
124
|
38K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
Spidey999
|
124 |
38K |
0 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
124
|
38K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Files US Patent : METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES
|
|
Spidey999
|
50 |
18K |
4 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
50
|
18K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Files US Patent : METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES
|
|
Spidey999
|
50 |
18K |
2 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
50
|
18K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
Spidey999
|
429 |
130K |
2 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
429
|
130K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
Spidey999
|
429 |
130K |
5 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
429
|
130K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Burn the Shorts Burn the shorts-
|
|
Spidey999
|
3 |
998 |
0 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
3
|
998
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Novartis - Heart Failure - Primary Endpoints
|
|
Spidey999
|
100 |
27K |
4 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
100
|
27K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Spidey999
|
1.1K |
313K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
Spidey999
|
255 |
83K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
255
|
83K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Clarity around Annoucements
|
|
Spidey999
|
14 |
4.2K |
3 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
14
|
4.2K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
Spidey999
|
811 |
334K |
5 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
811
|
334K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Spidey999
|
13K |
5.0M |
7 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
Spidey999
|
1.0K |
503K |
7 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
1.0K
|
503K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Spidey999
|
555 |
268K |
4 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
268K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
FDA REJECTS MESOBLAST APPLICATION
|
|
Spidey999
|
67 |
41K |
4 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
67
|
41K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Market Manipulation
|
|
Spidey999
|
6 |
4.5K |
1 |
13/09/20 |
13/09/20 |
ASX - By Stock
|
6
|
4.5K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
Spidey999
|
25K |
12M |
2 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
25K
|
12M
|
2
|
|
Charts
|
BAL |
Re:
BAL - Chart
|
|
Spidey999
|
3.7K |
1.7M |
1 |
26/07/19 |
26/07/19 |
Charts
|
3.7K
|
1.7M
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
Spidey999
|
25K |
12M |
1 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
25K
|
12M
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
Spidey999
|
25K |
12M |
7 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
25K
|
12M
|
7
|
|